Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chiang Mai Ram Medical Business PCL's revenue for the
three
months ended in Jun. 2026 was ฿599 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ฿1,167 Mil.
Chiang Mai Ram Medical Business PCL's Revenue per Share for the
three
months ended in Jun. 2026 was ฿0.15.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ฿0.29.
Warning Sign:
Chiang Mai Ram Medical Business PCL revenue per share has been in decline for the last 5 years.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Chiang Mai Ram Medical Business PCL Revenue Related Terms
Chiang Mai Ram Medical Business PCL Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Chiang Mai Ram Medical Business PCL's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chiang Mai Ram Medical Business PCL Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chiang Mai Ram Medical Business PCL's Revenue distribution charts can be found below:
* The bar in red indicates where Chiang Mai Ram Medical Business PCL's Revenue falls into.
Chiang Mai Ram Medical Business PCL Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿1,167 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chiang Mai Ram Medical Business PCL (BKK:CMR) has a Revenue of ฿1,167 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Chiang Mai Ram Medical Business PCL and its competitors.
Is Chiang Mai Ram Medical Business PCL's Revenue too high?
Chiang Mai Ram Medical Business PCL's current Revenue is ฿1,167 Mil. Overall, Chiang Mai Ram Medical Business PCL has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chiang Mai Ram Medical Business PCL's Revenue compare to HCA and THC?
Chiang Mai Ram Medical Business PCL's Revenue of ฿1,167 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Chiang Mai Ram Medical Business PCL and its competitors. Chiang Mai Ram Medical Business PCL's current Revenue is ฿1,167 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chiang Mai Ram Medical Business PCL stock overvalued right now?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL (BKK:CMR) is currently considered Significantly Overvalued. The stock's GF Value™ is ฿0.54, compared to a current price of ฿1.25 — trading 131.5% above its estimated fair value. The current Revenue is ฿1,167 Mil. Chiang Mai Ram Medical Business PCL's overall GF Score™ is 36/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Chiang Mai Ram Medical Business PCL (BKK:CMR), the current Revenue is ฿1,167 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chiang Mai Ram Medical Business PCL (BKK:CMR) Overvalued in 2026?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL stock appears to be overvalued.
The current stock price of ฿1.25 is trading 131.5% above its estimated GF Value™ of ฿0.54.
GuruFocus considers Chiang Mai Ram Medical Business PCL to be Significantly Overvalued.
Key valuation signals for BKK:CMR:
Revenue: ฿1,167 Mil
GF Value™: ฿0.54 vs. price of ฿1.25 (131.5% above fair value)
No single metric tells the full story. See the BKK:CMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chiang Mai Ram Medical Business PCL is a Thailand-based company. It provides medical services in the nature of General Hospital, Hospital in Social Security, and the national health security office systems. It offers various medical services including a Dental center, X-ray mobile for a checkup, CT Multislice, Cardiac Catheterization Center, Back pain center, Gynecologic Cancer center, Physical therapy, Operating theatres, Laboratory, Ambulance Services, and Health checkup center, and others. The company provides medical services through the Lanna Hospital.
36GF Score
Get the complete analysis for BKK:CMR
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:CMR has been successfully added to your 
